Specifically, ACOT4, DDOST, IRF5, MAP2K2, MCM2, PBX2, S100P, and SSBP1 had significant (p < 0.05) upregulation in invasive carcinoma compared with normal breast tissues (Figure 2B). This evidence concerns the gene PBX2 and invasive carcinoma.